ASTRAZENECA

ASTRAZENECA is UK Based Pharmaceutical and Bio-Technology Company. In the fight against COVID-19,Astrazeneca is one among World Top 5 Companies which is in advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.

Annual Results Summary:

AstraZeneca PLC - Annual Results - Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Operating Income	Net Profit	EPS (USD)
Dec-2021	37,417	1,056	112	0.08
Dec-2020	26,217	3,694	3,196	2.43
Dec-2019	24,384	1,702	1,335	0.52
Dec-2018	22,090	1,510	2,155	0.85
Dec-2017	22,465	2,292	3,001	1.19

Balance Sheet Summary

AstraZeneca PLC - Balance Sheet Summary - in Million USD:

Astrazeneca Total Assets as on September-2021 was 107,221 Million USD.

Astrazeneca Total Liabilities as on September-2021 was 67,309 Million USD.

Astrazeneca Total Equity as on September-2021 was 39,912 Million USD.

Quarterly Results Summary:

AstraZeneca PLC - Quarterly Results - Revenue and Net Profit - in Million USD:

Quarter - Ending	Revenue	Net Profit	EPS (USD)
Dec-2021	12,011	-292 (Loss)	-347 (Loss)
Sep-2021	9,866	-1,652	-0.55
Jun-2021	8,220	550	0.21
Mar-2021	7,320	1,561	0.59
Dec-2020	7,410	1,012	0.39
Sep-2020	6,578	651	0.49
Jun-2020	6,275	837	0.56
Mar-2020	6,354	780	0.30
Dec-2019	6,664	313	0.12
Sep-2019	6,406	299	0.11
Jun-2019	5,823	130	0.05
Mar-2019	5,491	593	0.23

Comments

Oxford Vaccine Trials again resumed by Astrazeneca

Oxford Vaccine Trials again resumed by Astrazeneca after UK Regulatory Authorities had given permission to go ahead with trials. Post one person undergoing trials had fallen ill, Astrazeneca temporarily paused trials of Oxford Vaccine.

Then again after review, as UK health regulatory authorities had given permission to go ahead with trials, again Oxford Vaccine Trials started.

Russia vaccine and Oxford vaccine are two vaccines related to Covid-19, that are in most advance stages of testing.

Sun, 13/09/2020 - 14:51